InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

Current share price for MVP : $0.460 0.005 (1.10%)+

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Change of Director's Interest Notice 9 Sep 2020 11:27AM $5.470 $0.460 fallen by 91.59%
$52 MVP Roadshow Presentation 1 Sep 2020 8:14AM $5.930 $0.460 fallen by 92.24%
$52 Corporate Governance Statement 20 Aug 2020 3:14PM $6.310 $0.460 fallen by 92.71%
$52 Appendix 4G 20 Aug 2020 3:13PM $6.310 $0.460 fallen by 92.71%
$52 Preliminary Final Report and Full Year Accounts 20 Aug 2020 3:03PM $6.300 $0.460 fallen by 92.70%
$52 Head of Europe Appointed 19 Aug 2020 9:33AM $6.250 $0.460 fallen by 92.64%
$52 Medical Developments to take control of EU markets 19 Aug 2020 9:07AM $6.250 $0.460 fallen by 92.64%
$52 Trading Halt 18 Aug 2020 8:42AM $6.250 $0.460 fallen by 92.64%
$52 Ceasing to be a substantial holder 30 Jul 2020 6:17PM $6.050 $0.460 fallen by 92.40%
$52 Ceasing to be a substantial holder 13 Jul 2020 4:53PM $6.460 $0.460 fallen by 92.88%
$52 Change in substantial holding 10 Jul 2020 5:05PM $6.580 $0.460 fallen by 93.01%
$52 Proposed issue of Securities - MVP 2 Jul 2020 8:44AM $7.030 $0.460 fallen by 93.46%
$52 MVP Roadshow Presentation 30 Jun 2020 5:13PM $6.980 $0.460 fallen by 93.41%
$52 Forfeiture of unquoted options 29 Jun 2020 4:24PM $6.660 $0.460 fallen by 93.09%
$52 Becoming a substantial holder 16 Jun 2020 5:40PM $7.610 $0.460 fallen by 93.96%
$52 S&P DJI Announces June 2020 Quarterly Rebalance 12 Jun 2020 8:16AM $7.410 $0.460 fallen by 93.79%
$52 Change in substantial holding 2 Jun 2020 4:55PM $7.980 $0.460 fallen by 94.24%
$52 Initial Director's Interest Notice 26 May 2020 2:14PM $8.360 $0.460 fallen by 94.50%
$52 Non Executive Director Appointment - Christine Emmanuel 26 May 2020 8:28AM $8.460 $0.460 fallen by 94.56%
$52 Penthrox approved in Hungary 25 May 2020 11:44AM $7.990 $0.460 fallen by 94.24%
$52 Penthrox approved - Netherlands and Bosnia and Herzegovina 5 May 2020 8:55AM $7.080 $0.460 fallen by 93.50%
$52 Penthrox is approved in Thailand 28 Apr 2020 8:46AM $7.460 $0.460 fallen by 93.83%
$52 Appendix 2A 22 Apr 2020 11:30AM $7.080 $0.460 fallen by 93.50%
$52 Proposed issue of Securities - MVP 17 Apr 2020 12:11PM $7.570 $0.460 fallen by 93.92%
$52 Proposed issue of Securities - MVP 3 Apr 2020 9:12AM $5.620 $0.460 fallen by 91.81%

276 - 300 of 619 results

Page 12 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.